Search Results - "Food and Drug Administration"

Efficacy and disposal of drugs after the expiry date by Gurmeet S Sarla

Connect to this object online.

Photosensitivity From Avapritinib: Pharamacovigilance Analysis by Ajit Venkatakrishnan, Brandon Chu, Pushkar Aggarwal

Connect to this object online.

Late Neurological Consequences of Zika Virus Infection: Risk Factors and Pharmaceutical Approaches by Isis N. O. Souza, Fernanda G. Q. Barros-Aragão, Paula S. Frost, Claudia P. Figueiredo, Julia R. Clarke

Connect to this object online.

Targeting cancer with antibody-drug conjugates: Promises and challenges by Alexis Q. Dean, Shen Luo, Julianne D. Twomey, Baolin Zhang

Connect to this object online.

Medical Marijuana Knowledge and Attitudes: A Survey of the California Pharmacists Association by Dara Szyliowicz, Peter Hilsenrath

Connect to this object online.

Sprinkle formulations-A review of commercially available products by Han Sol Lee, Jeong-Jun Lee, Myeong-Gyu Kim, Ki-Taek Kim, Cheong-Weon Cho, Dae-Duk Kim, Jae-Young Lee

Connect to this object online.

External Comparator Cohort studies - clarification of terminology by Gerd Rippin, Joan Largent, Wilhelmina Elisabeth Hoogendoorn, Héctor Sanz, Jaclyn Bosco, Christina Mack

Connect to this object online.

Pimavanserin: A Novel Antipsychotic With Potentials to Address an Unmet Need of Older Adults With Dementia-Related Psychosis by Ismaeel Yunusa, Marie Line El Helou, Saud Alsahali

Connect to this object online.

Systemic use of fluoroquinolone in children by Soo-Han Choi, Eun Young Kim, Yae-Jean Kim

Connect to this object online.

Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases by Prabhakar Bastola, Liujiang Song, Brian C. Gilger, Matthew L. Hirsch

Connect to this object online.

Practical clinical guidelines and pharmacological treatment for attention‐deficit hyperactivity disorder in Asia by Kentaro Kawabe, Fumie Horiuchi, Yu Matsumoto, Saori Inoue, Maya Okazawa, Rie Hosokawa, Kiwamu Nakachi, Junya Soga, Shu‐Ichi Ueno

Connect to this object online.

A Comprehensive Map of FDA-Approved Pharmaceutical Products by Hao Zhong, Ging Chan, Yuanjia Hu, Hao Hu, Defang Ouyang

Connect to this object online.

Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer by Guo L, Zhang H, Shao W, Chen B

Connect to this object online.

The effect of alcohol on ionizing and non-ionizing drug release from hydrophilic, lipophilic and dual matrix tablets by Václav Lochař, Alena Komersová, Kevin Matzick, Barbora Slezáková, Martin Bartoš, Jitka Mužíková, Samir Haddouchi

Connect to this object online.

The Clinical Trials Transformation Initiative (CTTI) by Alberto Grignolo

Connect to this object online.

REGEN-COV and COVID-19, update on the drug profile and FDA status: A mini-review and bibliometric study by Saeid Mezail Mawazi, Jiyauddin Khan, Noordin Othman, Sultan Othman Alolayan, Yaser M. Alahmadi, Sultan S. Al Thagfan, Sally A. Helmy, Roy Rillera Marzo

Connect to this object online.

Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting by Unnati Garg, Swati Chauhan, Upendra Nagaich, Neha Jain

Connect to this object online.

Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency by Danilo Fintini, Claudia Brufani, Marco Cappa

Connect to this object online.

Patient-reported outcomes in vaccines research: relevance for decision-making by Desmond Curran, Eliazar Sabater Cabrera, Linda Nelsen

Connect to this object online.

Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes by Ricchi P, Marsella M

Connect to this object online.